Recombinant human interleukin-2 (rhIL-2) (Weilun Pharma)
重组人白介素-2（125Ser）（卫伦生物）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameRecombinant human interleukin-2 (rhIL-2) (Weilun Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2005/01/20
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGuangdong Wellen Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesGuangdong Wellen Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A